• The Cost-Effectiveness of Continuous Versus Intermittent Renal Replacement Therapies in Acute Kidney Injury: Perspective of the Social Services for the Elderly in Argentina

    Dec 1, 2019, 00:00

  • Budget Impact of Cryoablation Versus Radiofrequency Ablation of Atrial Fibrillation in the Brazilian Public Healthcare System

    Dec 1, 2019, 00:00

  • New Challenges in Oncology for the Brazilian Private Health Sector: Specialists' Concerns After the ISPOR International Congress in Boston, Massachusetts, 2017

    Dec 1, 2019, 00:00

  • Epidemiología, consumo de recursos y costos del manejo médico de la Hepatitis C en Argentina, Colombia, Uruguay y Venezuela

    Dec 1, 2019, 00:00

  • PIT7 THE PROFILE OF FIREARMS INJURIES IN BRAZIL BETWEEN 2009 AND 2016

    Oct 1, 2019, 00:00

  • PCN29 TENDENCIAS EN LA MORTALIDAD DEL CANCER DE MAMA EN COLOMBIA EN MUJERES MAYORES DE 60 AÑOS

    Oct 1, 2019, 00:00

  • PDG9 EVALUACIÓN PARA LA SELECCIÓN DE PRECIO MÁXIMO DE VENTA DE MEDICAMENTOS

    Oct 1, 2019, 00:00

  • EP4 HOW IS SELF-PERCEIVED HEALTH STATUS (EQ-5D) ASSOCIATED WITH SOCIOECONOMIC CONDITIONS IN 22 LATIN AMERICAN COUNTRIES?

    Oct 1, 2019, 00:00

  • PRS9 ESTIMATIVA DO CUSTO DA ASMA EM UM PLANO DE SAUDE NO BRASIL - ESTUDO DE MUNDO REAL

    Oct 1, 2019, 00:00

  • PIH15 CURRENT PANORAMA OF THE SURGICAL TREATMENT OF ENDOMETRIOSIS BY THE BRAZILIAN PUBLIC SYSTEM

    Oct 1, 2019, 00:00

  • PNS31 A VIA ADMINISTRATIVA COMO UMA ALTERNATIVA DE ACESSO AO MEDICAMENTO NO SISTEMA ÚNICO DE SAÚDE: SOLUÇÃO OU PROBLEMA?

    Oct 1, 2019, 00:00

  • PDG16 ACESSO A INFORMAÇÕES E SERVIÇOS PRESTADOS PELA SUPERINTENDÊNCIA DE ASSISTÊNCIA FARMACÊUTICA DO ESTADO DE MINAS GERAIS POR MEIO DO APLICATIVO MGAPP

    Oct 1, 2019, 00:00

  • PCV13 EFECTIVIDAD DEL CATETER VENOSO DE INSERCION CENTRAL VS EL CATETER VENOSO CENTRAL DE INSERCION PERIFERICA EN EL TRATAMIENTO DE PACIENTES EN LA UNIDAD DE CUIDADOS INTENSIVOS.

    Oct 1, 2019, 00:00

  • CE3 ECONOMIC EVALUATION OF THE USE OF PRE-FILLED SYRINGE VERSUS MANUALLY FILLED SYRINGE PARAFLUSHING IN PATIENTS WITH CENTRAL VENOUS CATHETER IN THE PERSPECTIVE OF HEALTH CAREERS

    Oct 1, 2019, 00:00

  • PMD8 COST-EFFECTIVENESS OF THERMOABLATION VERSUS SURGERY FOR TREATMENT OF LIVER METASTASIS

    Oct 1, 2019, 00:00

  • PRO12 LITERATURE REVIEW OF CHALLENGES AND OPPORTUNITIES IN HEALTH ECONOMIC EVALUATION METHODOLOGY IN RARE DISEASES

    Oct 1, 2019, 00:00

  • PBI7 CASE STUDY: ECONOMICAL ANALYSIS OF WASTE IN BIOLOGICAL PRODUCTS IN AN INSTITUTION IN COLOMBIA

    Oct 1, 2019, 00:00

  • PBI11 ESTUDIOS DE SINTESIS Y TOMA DE DECISIONES: A PROPOSITO DE LA CONTINUACION DEL TRATAMIENTO CON UN BIOSIMILAR EN PACIENTES QUE RECIBEN INFLIXIMAB EN EL SEGURO SOCIAL EN SALUD EN PERU

    Oct 1, 2019, 00:00

  • PNS50 ANALISIS DE IMPACTO DE LA IMPLEMENTACION DE UNA RED INTEGRADA MEDIANTE LA MEDIDA DE CALIDAD DE VIDA RELACIONADA CON LA SALUD EN POBLACION COLOMBIANA

    Oct 1, 2019, 00:00

  • PSY6 HUMANISTIC AND ECONOMIC BURDEN OF DISEASE FOR PSORIASIS IN ARGENTINA, BRAZIL, COLOMBIA AND MEXICO

    Oct 1, 2019, 00:00

  • MT3 ICD THERAPY FOR SUDDEN CARDIAC ARREST PREVENTION IS POTENTIALLY COST-EFFECTIVE IN THE 1.5 PRIMARY PREVENTION POPULATION IN COLOMBIA: AN ECONOMIC EVALUATION OF THE IMPROVED SCA STUDY

    Oct 1, 2019, 00:00

  • PMD3 ANALISIS DE IMPACTO PRESUPUESTARIO SOBRE LA INCORPORACION DEL COCIENTE SFLT-1/PLGF PARA PREDECIR EL RIESGO DE PREECLAMPSIA EN EL SANATORIO FINOCHIETTO DE ARGENTINA

    Oct 1, 2019, 00:00

  • PCN63 COSTOS ASOCIADOS AL MANEJO DE PACIENTES CON CARCINOMA HEPATOCELULAR EN EL REGIMEN CONTRIBUTIVO

    Oct 1, 2019, 00:00

  • PIH19 CONTRASTE DE MODELOS DE PROBABILIDAD DICOTOMICOS PARA LA ESTIMACION DE PARTOS Y CESAREAS EN UNA ENTIDAD PROMOTORA DE SALUD COLOMBIANA

    Oct 1, 2019, 00:00

  • PMD1 PATIENT OUTCOMES IN CENTRIFUGE AND MEMBRANE THERAPEUTIC PLASMA EXCHANGE (TPE): LITERATURE REVIEW WITH A FOCUS ON THE CHILEAN COLOMBIAN MARKETS

    Oct 1, 2019, 00:00

  • PDB7 COST COMPARISON OF BOVINE PERICARDIUM (BP) VS. BIOCOMPATIBLE GLYCOLIDE COPOLYMER BUTTRESS IN GASTRIC STAPLE LINE REINFORCEMENT (SLR)

    Oct 1, 2019, 00:00

  • PGI3 IMPACT OF DOSE ESCALATION ON TREATMENT COST OF IMMUNOBIOLOGICAL THERAPIES FOR CROHN'S DISEASE FROM THE BRAZILIAN PRIVATE PAYER PERSPECTIVE

    Oct 1, 2019, 00:00

  • PMS13 A ROUTE FOR THE CORRECT DIAGNOSIS OF RHEUMATOID ARTHRITIS - AN OPPORTUNITY TO AVOID MISDIAGNOSIS AND COSTS ASSOCIATED

    Oct 1, 2019, 00:00

  • PND19 RETROSPECTIVE ANALYSIS OF MULTIPLE SCLEROSIS TREATMENT PROFILE AND PATTERNS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM

    Oct 1, 2019, 00:00

  • PSU5 ANALISIS COSTE CONSECUENCIA DEL TRASPLANTE DE PROGENITORES HEMATOPOYETICOS DE DONANTE NO RELACIONADO FINANCIADO POR EL FONDO INTANGIBLE SOLIDARIO DE SALUD DEL PERU

    Oct 1, 2019, 00:00

  • PIN15 PUBLIC HEALTH IMPACT OF DENGUE VACCINATION WITH SCREENING IN BRAZIL

    Oct 1, 2019, 00:00

  • PCN12 COST-EFFECTIVENESS OF PEMBROLIZUMAB COMPARED TO CHEMOTHERAPY AS A TREATMENT FOR PATIENTS WITH PREVIOUSLY TREATED ADVANCED MELANOMA IN CHINA

    Oct 1, 2019, 00:00

  • PNS30 CHANGES IN THE OWNERSHIP STRUCTURE OF HUNGARIAN HEALTH CARE PROVIDERS

    Oct 1, 2019, 00:00

  • PUK5 POTENTIALLY INAPPROPRIATE PRESCRIPTIONS OF ANTICHOLINERGIC DRUGS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

    Oct 1, 2019, 00:00

  • PMS2 SUCCESSFUL IMPLEMENTATION OF A COMPREHENSIVE CARE PROGRAM IN RHEUMATOID ARTHRITIS WITH SIGNIFICANT COST-SAVINGS FOR THE HEALTH SYSTEM

    Oct 1, 2019, 00:00

  • PNS1 ¿EXISTE SUFICIENTE EVIDENCIA PARA USAR SUPERVIVENCIA GLOBAL Y CALIDAD DE VIDA COMO DESENLACES CRÍTICOS EN LA TOMA DE DECISIONES EN SALUD?

    Oct 1, 2019, 00:00

  • PCN45 COMPARATIVE ANALYSIS OF BRA CMED, GER G-BA AND FRA HAS ASSESSMENT SCORES FOR ONCOLOGY THERAPIES

    Oct 1, 2019, 00:00

  • PIN22 LOS COSTOS DE LA NEUMONIA ADQUIRIDA EN LA COMUNIDAD Y LA LACTANCIA MATERNA COMO FACTOR DE PROTECCION EN MENORES DE 5 ANHOS EN HOSPITAL PUBLICO DEL PERU

    Oct 1, 2019, 00:00

  • PNS49 EVOLUTION AND RESULTS OF HEALTHCARE PERFORMANCE INDICATORS IN BRAZILIAN SELF-FUNDED HEALTH PLANS

    Oct 1, 2019, 00:00

  • CM2 REMOTE MONITORING AFTER THE IMPLANTATION OF A CARDIOVERTER-DEFIBRILLATOR: A SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2019, 00:00

  • PIN27 USO DE LA REGRESIÓN BETA EN EL ANALISIS DE ASOCIACIÓN ENTRE LOS ÍNDICES EQ-5D-5L, EQ-EVA Y POTENCIALES COVARIABLES EN PACIENTES CON VIH/SIDA EN COLOMBIA

    Oct 1, 2019, 00:00

  • PCN14 COSTOS INDIRECTOS DEL CANCER DE MAMA EN COLOMBIA: 1990-2016.

    Oct 1, 2019, 00:00

  • PSU4 BUDGET IMPACT ANALYSIS OF TRICLOSAN-COATED SUTURES FOR SURGICAL SITE INFECTION PREVENTION IN COLOMBIA

    Oct 1, 2019, 00:00

  • EP1 SCHOOL ENVIRONMENT FACTORS ASSOCIATED WITH ADOLESCENTS BMI IN BRAZIL

    Oct 1, 2019, 00:00

  • CL3 ESTUDIO DE EVALUACIÃN ECONÃMICA DEL APÃSITO TRANSPARENTE IMPREGNADO CON CLORHEXIDINA, PARA LA FIJACIÃN DE CATÃTERES CENTRALES BAJO EL CONTEXTO DE LOS HOSPITALES PÃBLICOS DE REPáBLICA DOMINICANA: CASO HOSPITAL DOCENTE PADRE BILLINI, AÃO ...

    Oct 1, 2019, 00:00

  • PCN3 BRAND-BRAND ONCOLOGY COMBINATIONS: HURDLES AND IMPLICATIONS

    Oct 1, 2019, 00:00

  • PIH6 APPROACH TO THE IMPACT OF COVERAGE IN LONG-TERM CONTRACEPTION IN THE ECONOMIC BURDEN OF UNPLANNED PREGNANCY FROM THE PERSPECTIVE OF ISAPRES IN CHILE

    Oct 1, 2019, 00:00

  • PNS24 GASTOS COM MEDICAMENTOS E SEU IMPACTO NA RENDA DAS FAMÍLIAS BRASILEIRAS

    Oct 1, 2019, 00:00

  • CR3 COSTOS DIRECTOS Y CUMPLIMIENTO DE INDICADORES DE CONTROL METABOLICO EN PACIENTES CON DIABETES MELLITUS TIPO 2 EN UN HOSPITAL PUBLICO DE COLOMBIA

    Oct 1, 2019, 00:00

  • PIH10 NATIONWIDE, REAL-WORLD HEALTH INSURANCE TREATMENT COST OF INFERTILITY IN HUNGARY: A COST OF ILLNESS STUDY

    Oct 1, 2019, 00:00

  • PCV7 BUDGET IMPACT OF GLOBAL LONGITUDINAL STRAIN FOR THE EARLY DETECTION OF CARDIOTOXICITY INCORPORATION IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    Oct 1, 2019, 00:00

  • PIN10 PUBLIC HEALTH AND ECONOMIC IMPACT OF A HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM FOR FEMALES AGED 9 YEARS IN EL SALVADOR

    Oct 1, 2019, 00:00

  • PIH8 MODEL TO APPROACH TO THE ECONOMIC BURDEN OF UNPLANNED PREGNANCY IN CHILE: THE IMPACT OF THE FAILURE OF COMPLIANCE OF THE CONTRACEPTIVE METHODS.

    Oct 1, 2019, 00:00

  • PNS7 THE PRICE OF SUBSTITUTE TECHNOLOGIES

    Oct 1, 2019, 00:00

  • PND14 OUT-OF-POCKET EXPENDITURE IN MIGRAINE PATIENTS WITH AND WITHOUT COMORBIDITIES IN CHILE: A HEALTHCARE SYSTEM PERSPECTIVE

    Oct 1, 2019, 00:00

  • PCN33 PERTUZUMAB+TRASTUZUMAB TREATMENT ON HER2+ EARLY BREAST CANCER: LONG-TERM REDUCTION OF METASTASIC BREAST CANCER INCIDENCE IN ARGENTINA.

    Oct 1, 2019, 00:00

  • PNS20 REPORTS OF SUBSTANDARD MEDICINES: AN ANALYSIS OF THE BRAZILIAN HEALTH SURVEILLANCE NOTIFICATION SYSTEM

    Oct 1, 2019, 00:00

  • PCN42 JUDICIALIZATION OF ACCESS TO MEDICINES IN ONCOLOGY: SYSTEMATIZED REVIEW

    Oct 1, 2019, 00:00

  • PMS17 PATIENT PREFERENCES FOR BIOLOGIC AND BIOSIMILAR OSTEOPOROSIS TREATMENTS IN COLOMBIA: A DISCRETE-CHOICE EXPERIMENT

    Oct 1, 2019, 00:00

  • CV1 CARDIOVASCULAR RISK IN DIABETES PATIENTS MONITORED BY A MOBILE PHONE APP HEALTH CARE PROGRAM IN BRAZIL

    Oct 1, 2019, 00:00

  • PMU13 A MULTI-CRITERIA APPROACH TO THE STUDY OF CHRONIC NON-COMMUNICABLE DISEASES IN BRAZIL

    Oct 1, 2019, 00:00

  • PSU6 ESTUDIO DE COSTO EFECTIVIDAD ENTRE HEPARINA NO FRACCIONADA Y HEPARINAS DE BAJO PESO MOLECULAR EN PACIENTES SOMETIDOS A ARTROPLASTIA TOTAL DE CADERA ELECTIVA

    Oct 1, 2019, 00:00

  • PMD13 BUNDLE AND RISK SHARING FOR BARIATRIC SURGERY UNDER THE VALUE-BASED CARE (VBC) MODEL: MODEL EFFECTIVENESS AND SUSTAINABILITY AT HOSPITAL ALEMAO OSWALDO CRUZ (HAOC) BASED IN CLINICAL AND ECONOMICAL RESULTS

    Oct 1, 2019, 00:00

  • PCV6 ECONOMIC EVALUATION OF GLOBAL LONGITUDINAL STRAIN IN THE EARLY DETECTION OF CARDIOTOXICITY IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    Oct 1, 2019, 00:00

  • PIN28 COSTS OF PERTUSSIS IN BRAZIL: A NINE-YEAR EVALUATION

    Oct 1, 2019, 00:00

  • PNS43 ESTIMACIÓN DE UN COSTO DE REFERENCIA PARA EVENTOS HOSPITALARIOS MEDIANTE NORMALIZACIÓN DE DATOS

    Oct 1, 2019, 00:00

  • PBI1 THE VALUE OF ONASEMNOGENE ABEPARVOVEC (AVXS-101) AS A COST-EFFECTIVE GENE REPLACEMENT THERAPY FOR SPINAL MUSCULAR ATROPHY TYPE 1 IN IMPROVING SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND MOTOR FUNCTION

    Oct 1, 2019, 00:00

  • PBI3 ANÁLISIS DEL COSTO POR RESPONDEDOR DE SECUKINUMAB VS INFLIXIMAB Y ETANERCEPT PARA EL TRATAMIENTO DE LA ARTRITIS PSORIÁSICA DESDE UNA PERSPECTIVA ECUATORIANA

    Oct 1, 2019, 00:00

  • PND6 THE DIRECT COSTS OF MULTIPLE SCLEROSIS IN A GROUP OF COLOMBIAN PATIENTS

    Oct 1, 2019, 00:00

  • PMU10 RESULTADOS DE IMPLEMENTACION DE PROGRAMA DE CUIDADOS PALIATIVOS EN UNA ASEGURADORA EN SALUD EN COLOMBIA

    Oct 1, 2019, 00:00

  • PCN16 COST ESTIMATE ANALYSIS OF ABIRATERONE PLUS PREDNISONE (AAP) AND ENZALUTAMIDE (ENZ) IN INSURED METASTATIC CASTRATION RESISTANT PROSTATE CANCER PATIENTS IN ARGENTINA: EVIREPRO DATABASE

    Oct 1, 2019, 00:00

  • PNS12 THE IMPACT OF THE POSTPONEMENT OF MATERNITY ON WOMEN'S INCOME IN BRAZIL

    Oct 1, 2019, 00:00

  • PNS22 DESCRIBING GAPS IN ACCESS TO HEALTHCARE BETWEEN INTERNATIONAL MIGRANTS AND THE CHILEAN-BORN POPULATION

    Oct 1, 2019, 00:00

  • PRO3 DIRECT COSTS OF HEMOPHILIA CARE, THE CASE OF A HEALTH INSURER IN COLOMBIA

    Oct 1, 2019, 00:00

  • PGI5 BURDEN OF LIVER DISEASE, COLOMBIA 2009-2016

    Oct 1, 2019, 00:00

  • HI1 PRELIMINARY COST ANALYSIS OF MISDIAGNOSIS OF RHEUMATOID ARTHRITIS

    Oct 1, 2019, 00:00

  • PIH2 COST-EFFECTIVENESS ANALYSIS OF MEDICINES FOR CONTROLLED OVARIAN STIMULATION IN THE TREATMENT OF INFERTILITY IN PATIENTS WITH AN SUBOPTIMAL OVARIAN RESPONSE IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • PMS10 NATIONWIDE ANNUAL HEALTH INSURANCE TREATMENT COST OF JUVENILE AND ADOLESCENT IDIOPATHIC SCOLIOSIS IN HUNGARY: COST OF ILLNESS STUDY BASED ON REAL WORLD DATA

    Oct 1, 2019, 00:00

  • MT2 REMOTE MONITORING COMPARED TO CONVENTIONAL FOLLOW-UP FOR PATIENTS WITH HEART FAILURE USING IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR: A BUDGET IMPACT ANALYSIS

    Oct 1, 2019, 00:00

  • PMS8 CONVENTIONAL VERSUS BIOLOGICAL TREATMENT FOR ANKYLOSING SPONDYLITIS. RESULTS FROM A REAL-LIFE SETTING

    Oct 1, 2019, 00:00

  • PMH10 TREATMENT-RESISTANT DEPRESSION IN LATIN AMERICA: PRELIMINARY RESULTS FROM THE TRAL STUDY

    Oct 1, 2019, 00:00

  • PMH6 COST-EFFECTIVENESS OF ANTIPSYCHOTIC DRUGS FOR FIRST- AND SECOND-LINE TREATMENT OF SCHIZOPHRENIA IN BRAZIL

    Oct 1, 2019, 00:00

  • PCV2 TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) IN ARGENTINA: META-ANALYSIS OF REAL-LIFE DATA

    Oct 1, 2019, 00:00

  • PAM2 GESTION DE SOPORTE NUTRICIONAL EN CUIDADOS INTENSIVOS

    Oct 1, 2019, 00:00

  • PAM6 COMPLEMENTARY AND INTEGRATIVE THERAPIES IN BRAZIL'S UNIFIED HEALTHCARE SYSTEM (SUS) IN 2017: AN UNDERREPORTING CASE

    Oct 1, 2019, 00:00

  • PCN20 COSTO EFECTIVIDAD DE LA UTILIZACIÓN DE INHIBIDORES DE PUNTOS DE CONTROL INMUNITARIO (ANTI-PD1/ANTI-CTLA4) Y TERAPIAS DIRIGIDAS (BRAFI/MEKI) EN EL TRATAMIENTO DEL MELANOMA AVANZADO.

    Oct 1, 2019, 00:00

  • PCN15 IMPACTO ECONOMICO DE LAS COMPLICACIONES OSEAS EN PACIENTES CON CANCER DE MAMA METASTASICO (CAMM) EN MEXICO.

    Oct 1, 2019, 00:00

  • PRO1 MEDICAL THERAPY FOR PULMONARY ARTERIAL HYPERTENSION (PAH): AN INDIRECT TREATMENT COMPARISON OF MACITENTAN AND BOSENTAN

    Oct 1, 2019, 00:00

  • PMU9 ESTABLISHING CHILE RICARTE SOTO LAW REIMBURSEMENT CAP IN THE FACE OF GENERIC COMPETITION

    Oct 1, 2019, 00:00

  • PCN23 IMPACTO ECONOMICO DE CANCER DE CUELLO UTERINO Y SU TENDENCIA AL 2030 EN EL SISTEMA DE SALUD PUBLICO DEL PERU

    Oct 1, 2019, 00:00

  • PNS10 THE PENALTY OF MATERNITY FOR LABOR MARKET IN BRAZIL

    Oct 1, 2019, 00:00

  • PMD12 HOW MUCH CAN COLOMBIAN HOSPITALS EARN FOR EACH THERAPEUTIC PLASMA EXCHANGE (TPE) PROCEDURE? A MULTI-CENTER, COST COMPARISON STUDY BETWEEN CENTRIFUGAL AND MEMBRANE SYSTEMS

    Oct 1, 2019, 00:00

  • PIN11 COST-EFFECTIVENESS OF INTERFERON-GAMMA RELEASE ASSAY COMPARED TO TUBERCULIN SKIN TEST FOR DETECTION OF LATENT TUBERCULOSIS IN PATIENTS WITH RENAL FAILURE UNDERGOING HEMODIALYSIS

    Oct 1, 2019, 00:00

  • PSY8 CURRENT PRACTICE AND RESOURCE USE ASSOCIATED WITH TREATMENT OF VENOUS THROMBOEMBOLISM DISEASE IN SOCIAL SECURITY SECTOR OF ARGENTINA

    Oct 1, 2019, 00:00

  • PNS44 COORDENAÇÃO DE CUIDADOS DE SAÚDE ATRAVÉS DE UM APLICATIVO MÓVEL COMO FATOR DE MELHOR RESULTADO CLÍNICO E REDUÇÃO DE CUSTOS

    Oct 1, 2019, 00:00

  • PDB3 PHARMACIST LED INTERVENTION ON HEALTH-RELATED QUALITY OF LIFE OF DIABETIC PATIENTS AND ITS RELATIONSHIP WITH PATIENT DEMOGRAPHICS ON EQ-5D DOMAINS AND VAS SCORE

    Oct 1, 2019, 00:00

  • PCN1 EFECTIVIDAD Y SEGURIDAD DEL ESQUEMA DABRAFENIB-TRAMETINIB EN EL TRATAMIENTO DEL MELANOMA AVANZADO/METASTÁSICO IRRESECABLE CON MUTACIÓN BRAF V600: REVISIÓN SISTEMÁTICA DE LA LITERATURA Y METANÁLISIS EN RED

    Oct 1, 2019, 00:00

  • PCV4 ANNUAL HEALTH INSURANCE TREATMENT COST OF HYPERTENSIVE RENAL DISEASE IN HUNGARY: COST OF ILLNESS STUDY BASED ON REAL WORLD DATA

    Oct 1, 2019, 00:00

  • PMS1 SUSTAINED REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS: EVIDENCE FROM A COHORT FOLLOWED-UP AT A CENTER OF EXCELLENCE IN COLOMBIA

    Oct 1, 2019, 00:00

  • PRS6 LA EVOLUCIÓN DE LA CARGA DE ENFERMEDAD DE LA FIBROSIS PULMONAR IDIOPÁTICA EN LA POBLACIÓN ECUATORIANA DE 2011 A 2017

    Oct 1, 2019, 00:00

  • PCN6 COSTO-EFECTIVIDAD DEL ESQUEMA DABRAFENIB EN COMBINACIÓN CON TRAMETINIB EN COMPARACIÓN CON OTRAS TERAPIAS DIRIGIDAS, INMUNOTERAPIA Y DACARBAZINA PARA EL TRATAMIENTO DE MELANOMA IRRESECABLE O METASTÁSICO CON MUTACIÓN BRAFV600 EN COLOMBIA ...

    Oct 1, 2019, 00:00

  • PRO13 IMPACT OF CAREGIVER EXPERIENCE AND HRQOL IN LATER-ONSET SPINAL MUSCULAR ATROPHY (SMA): RESULTS FROM THE PHASE 3 CHERISH TRIAL

    Oct 1, 2019, 00:00

  • PMS11 EPIDEMIOLOGY, USE OF RESOURCES AND COST OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN ARGENTINA: AN EXTENSIVE REVIEW WITH EXPERT ELICITATION

    Oct 1, 2019, 00:00

  • PRO4 COST-EFFECTIVENESS ANALYSIS OF AN INTEGRATED EXTRACORPOREAL PHOTOPHERESIS SYSTEM VERSUS SELECTED TREATMENTS FOR REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE

    Oct 1, 2019, 00:00

  • PGI1 EFFECTS OF FECAL MICROBIOTA TRANSPLANTATION IN INFLAMMATORY BOWEL DISEASE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2019, 00:00

  • PCN18 ANTINEOPLASICOS ORAIS NA PRIMEIRA LINHA DE TRATAMENTO DE LEUCEMIA MIELOIDE CRONICA: UMA ANALISE DE CUSTO

    Oct 1, 2019, 00:00

  • PMU11 COMPARATIVE ASSESSMENT OF HTA OUTCOMES IN BRAZIL, CANADA AND THE UNITED KINGDOM

    Oct 1, 2019, 00:00

  • PMU8 DIFERENCIAS EN LA MORTALIDAD SEGUN LUGAR DE OCURRENCIA Y REGIMEN DE SALUD EN EL CARIBE COLOMBIANO, 2016

    Oct 1, 2019, 00:00

  • PRS2 COST ANALYSIS FOR THE TREATMENT OF SEVERE UNCONTROLLED BRONCHIAL ASTHMA IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • PMD4 ANALISIS DE IMPACTO PRESUPUESTARIO SOBRE LA INCORPORACION DEL COCIENTE SFLT-1/PLGF PARA PREDECIR EL RIESGO DE PREECLAMPSIA EN EL SISTEMA DE SALUD PUBLICO DE MENDOZA, ARGENTINA

    Oct 1, 2019, 00:00

  • PNS14 EVIDENCE ON THE POSTPONEMENT OF MATERNITY IN BRAZIL

    Oct 1, 2019, 00:00

  • CN2 EVALUACIÓN DE COSTO-EFECTIVIDAD DE LA ENZALUTAMIDA (ENZA) FRENTE A LA ABIRATERONA (ABI) PARA EL TRATAMIENTO DE PACIENTES CON CÁNCER DE PRÓSTATA RESISTENTE A LA CASTRACIÓN METASTÁSICO (CPRCM) ANTES DEL USO DE DOCETAXEL EN EL INSTITUTO ME ...

    Oct 1, 2019, 00:00

  • PCN28 OVARIAN CANCER MORTALITY TREND IN BRAZIL: A LINEAR REGRESSION ANALYSIS BETWEEN 1981 AND 2016

    Oct 1, 2019, 00:00

  • PBI10 REAL WORLD SWITCHING PATTERNS OF ETANERCEPT ORIGINAL AND BIOSIMILAR IN GERMANY

    Oct 1, 2019, 00:00

  • PBI4 COMPORTAMIENTO DE USO DE TERAPIA BIOLÓGICA Y COSTOS ASOCIADOS DE UN PROGRAMA DE ATENCIÓN EN PACIENTES CON DIAGNASTICO DE ARTRITIS REUMATOIDE EN COLOMBIA

    Oct 1, 2019, 00:00

  • PIN6 O IMPACTO ECONOMICO NA AVALIACAO DO INFECTOLOGISTA NO PROGRAMA DE GESTAO CLINICA DO USO DE ANTIMICROBIANOS EM HOSPITAL PRIVADO DE FORTALEZA- CE, BRASIL

    Oct 1, 2019, 00:00

  • CL2 EFFECTIVENESS OF TREATMENT WITH DIRECT-ACTING ANTIVIRALS IN THE COLOMBIAN POPULATION WITH CHRONIC HEPATITIS C

    Oct 1, 2019, 00:00

  • PDB14 LOVASTATIN, ATORVASTATIN AND ROSUVASTATIN CONSUMPTION IN COLOMBIA FROM 2010 TO 2017

    Oct 1, 2019, 00:00

  • TP1 TRATAMIENTO DEL CANCER DE MAMA ESTADIO IV, ANÃLISIS DE LOS DATOS REPORTADOS A LA CUENTA DE ALTO COSTO. COLOMBIA 2017

    Oct 1, 2019, 00:00

  • PMH7 COST-EFFECTIVENESS AND INCORPORATION PRICE OF ARIPIPRAZOLE FOR SCHIZOPHRENIA IN BRAZIL: A SUBSTITUTE TECHNOLOGY APPROACH

    Oct 1, 2019, 00:00

  • PSY5 QUALITY OF LIFE OF INDIVIDUALS WITH PSORIASIS IN LATIN AMERICA

    Oct 1, 2019, 00:00

  • PMU7 POPULATION HEALTH IMPACT MODEL

    Oct 1, 2019, 00:00

  • PIT6 SELF-INFLICTED LESIONS IN BRAZIL: A DESCRIPTIVE ANALYSIS BETWEEN 2009 AND 2016

    Oct 1, 2019, 00:00

  • PMU14 USO DEL EQ-5D EN MEXICO

    Oct 1, 2019, 00:00

  • PCV15 GOOD PRACTICES ASSESSMENT FOR CARDIAC SURGERIES: A REAL WORLD ANALYSIS

    Oct 1, 2019, 00:00

  • PMS5 USE OF AN ALGORITHM WITHIN A MULTIDISCIPLINARY CONSULTATION FOR THE MANAGEMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS CANDIDATES FOR BIOLOGICAL THERAPY - A STRATEGY FOR OPTIMIZING COSTS

    Oct 1, 2019, 00:00

  • PDB6 COSTO DE OBESIDAD Y SU TENDENCIA AL 2030 EN EL SISTEMA DE SALUD PUBLICO DEL PERU

    Oct 1, 2019, 00:00

  • PIN8 ANALISE ECONOMICA DE CUSTOS DE TRATAMENTO DE INFECCOES POR MICROORGANISMOS GRAM-POSITIVOS RESISTENTES: STAPHYLOCOCCUS AUREUS RESISTENTE A METICILINA (MRSA) E ENTEROCOCCUS SPP RESISTENTES A VANCOMICINA (VRE)

    Oct 1, 2019, 00:00

  • PDB11 BUDGET IMPACT ANALYSIS OF SWITCHING FROM ALOGLIPTIN TO VILDAGLIPTIN IN THE TREATMENT OF TYPE 2 DIABETES

    Oct 1, 2019, 00:00

  • PMS18 COST-ANALYSIS OF TREATMENT FOR MODERATE AND SEVERE RHEUMATOID ARTHRITIS IN A SPECIALIZED RHEUMATOLOGY CENTER

    Oct 1, 2019, 00:00

  • PCN37 FDA NEW DRUGS APPROVAL FOR BREAST, COLORECTAL, PROSTATE AND LUNG CANCER AND HORIZON SCANNING OPPORTUNITY

    Oct 1, 2019, 00:00

  • PIN9 PUBLIC HEALTH AND ECONOMIC IMPACT OF A GENDER-NEUTRAL QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM IN COLOMBIA

    Oct 1, 2019, 00:00

  • PSY4 BURDEN OF DISEASE FOR RHEUMATOID ARTHRITIS IN COLOMBIA AND BRAZIL

    Oct 1, 2019, 00:00

  • PCN41 IMPACT OF DISEASE RELATED GROUP IN BREAST CANCER TREATMENT IN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM

    Oct 1, 2019, 00:00

  • PDB4 COST-EFFECTIVENESS ANALYSIS OF SWITCHING FROM ALOGLIPTIN TO VILDAGLIPTIN IN THE TREATMENT OF TYPE 2 DIABETES

    Oct 1, 2019, 00:00

  • PIN3 COSTS AND CONSEQUENCES OF CEFTAROLINE FOSAMIL FOR THE TREATMENT OF COMPLICATED SKIN AND SOFT TISSUE INFECTIONS (CSSTI) IN BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    Oct 1, 2019, 00:00

  • PDG11 IMPLEMENTATION OF INDICATORS IN THE PROCESS OF ACQUISITION OF MEDICINES IN THE HOSPITAL UNITS OF THE STATE SECRETARIAT OF HEALTH OF SANTA CATARINA: THE USE OF THE ECONOMIC RATIO INDEX

    Oct 1, 2019, 00:00

  • PSU7 COST-EFFECTIVENESS ANALYSIS OF APIXABAN FOR THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER HIP OR KNEE REPLACEMENT SURGERY IN COLOMBIA

    Oct 1, 2019, 00:00

  • PMH1 COST-OF-ILLNESS STUDIES FOR DEPRESSION AND BIPOLAR DISORDER IN LATIN AMERICA: A SYSTEMATIC REVIEW

    Oct 1, 2019, 00:00

  • PNS2 COLOMBIA'S HEALTHCARE REFORM: COST-CONTAINMENT MECHANISMS AND IMPLICATIONS FOR SUSTAINABILITY

    Oct 1, 2019, 00:00

  • PNS23 EPIDEMIOLOGY OF MYELOPROLIFERATIVE DISORDERS: REAL WORLD DATA STUDY IN BRAZIL

    Oct 1, 2019, 00:00

  • PND5 COST-EFFECTIVENESS OF MECHANICAL THROMBECTOMY USING SOLITAIRE STENT RETRIEVER IN COMBINATION WITH INTRAVENOUS TISSUE PLASMINOGEN ACTIVATOR (IV-TPA) VERSUS IV-TPA ALONE FOR THE TREATMENT OF ACUTE ISCHAEMIC STROKE DUE TO LARGE VESSEL OCC ...

    Oct 1, 2019, 00:00

  • PRS4 HEALTH TECHNOLOGY ASSESSMENT OF DUPILUMAB IN SEVERE BRONCHIAL ASTHMA IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • PRO8 PROFILAXIS EN HEMOFILIA A CON INHIBIDORES EN COLOMBIA, ¿ES POSIBLE CONTAR CON TRATAMIENTOS QUE GENEREN AHORROS AL SISTEMA DE SALUD?

    Oct 1, 2019, 00:00

  • PNS54 AUDITORIA SOCIAL COMO FERRAMENTA DE ANALISE DA QUALIDADE DO ATENDIMENTO NA SAUDE

    Oct 1, 2019, 00:00

  • PNS42 A SURVEY OF PRACTICING PHYSICIANS ON VALUE-BASED HEALTH CARE IN A PRIVATE HEALTH SYSTEM IN BRAZIL

    Oct 1, 2019, 00:00

  • PRS8 HEALTH RESOURCE USE OF COPD PATIENTS IN THE BRAZILIAN PRIVATE HEALTHCARE SETTING

    Oct 1, 2019, 00:00

  • PDG8 COST-EFFECTIVENESS ANALYSIS OF MIDOSTAURIN (MIDO) + INTENSIVE CHEMOTHERAPY (SOC) FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA IN ADULTS WITH FLT3 MUTATION IN COLOMBIA

    Oct 1, 2019, 00:00

  • PNS11 FUNDING OF MANAGEMENT AND INCORPORATION OF TECHNOLOGIES IN BRAZILIAN HEALTH SYSTEM

    Oct 1, 2019, 00:00

  • PAM5 AVALIAÇÃO DO USO DA OZONIOTERAPIA EM PACIENTES COM DOR LOMBAR: UM ESTUDO DE METANALISE

    Oct 1, 2019, 00:00

  • PDG6 EVALUACION ECONOMICA DE DEXAMETASONA IMPLANTE PARA EL TRATAMIENTO DE PACIENTES CON EDEMA MACULAR DIABETICO

    Oct 1, 2019, 00:00

  • PND13 SYSTEMATIC REVIEW OF THE COST OF ILLNESS OF MULTIPLE SCLEROSIS

    Oct 1, 2019, 00:00

  • PCN36 EXPERIENCIAS EN LA IMPLEMENTACIÓN DE METODOLOGÍAS O CRITERIOS PARA DETERMINAR EL VALOR TERAPÉUTICO DE MEDICAMENTOS ONCOLÓGICOS: UNA REVISIÓN RÁPIDA DE LA LITERATURA

    Oct 1, 2019, 00:00

  • PMS7 A STANDARD COSTING FOR MODERATE-SEVERE RHEUMATOID ARTHRITIS FROM THE COLOMBIAN HEALTH SYSTEM PERSPECTIVE

    Oct 1, 2019, 00:00

  • PCV9 IMPACTO CLINICO Y ECONOMICO DE LAS ENFERMEDADES CARDIOVASCULARES (ECV) EN LA POBLACION ADULTA DENTRO DEL SISTEMA DE SALUD DE MEXICO.

    Oct 1, 2019, 00:00

  • PCN17 COSTO-EFECTIVIDAD DE AFATINIB COMO PRIMERA LÍNEA EN EL TRATAMIENTO DEL CÁNCER DE PULMÓN DE CÉLULAS NO PEQUEÑAS AVANZADO CON MUTACIÓN POSITIVA DEL RECEPTOR DEL FACTOR DE CRECIMIENTO EPIDÉRMICO EN COLOMBIA

    Oct 1, 2019, 00:00

  • PNS29 CHANGING OF HEALTH CARE TOURISM AND ITS RECOVERING ROLE FOR ECONOMY

    Oct 1, 2019, 00:00

  • PNS46 ATENCION VIRTUAL EN SALUD: DE LA ESTRATEGIA A LA TACTICA

    Oct 1, 2019, 00:00

  • PSY1 SECUKINUMAB VS ADALIMUMAB E INFLIXIMAB PARA EL TRATAMIENTO DE ESPONDILITIS ANQUILOSANTE: UN ANÁLISIS DE COSTO POR RESPONDEDOR A LA SEMANA 24 DESDE UNA PERSPECTIVA ECUATORIANA

    Oct 1, 2019, 00:00

  • PND11 ECONOMIC IMPACT OF INITIATING DIMETHYL FUMARATE VERSUS OTHER DISEASE MODYFING THERAPIES IN PUBLICLY INSURED BRAZILIAN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS

    Oct 1, 2019, 00:00

  • PRS7 ¿REALMENTE ES UNA AMENAZA PARA LA SALUD DE LOS COLOMBIANOS?

    Oct 1, 2019, 00:00

  • PNS39 HOW VALUE IS DEFINED BY DIFFERENT STAKEHOLDERS IN BRAZIL?

    Oct 1, 2019, 00:00

  • PSY11 ADESAO E CUSTOS ASSOCIADOS AO TRATAMENTO PROFILATICO DE PACIENTES HEMOFILICOS NO BRASIL

    Oct 1, 2019, 00:00

  • PMH2 THE ENVIRONMENT DISASTER OF BRAZILIAN MINING OF MARIANA IN THE HEALTH ECONOMIC CONTEXT: PSYCHOLOGICAL TRAGEDY COST

    Oct 1, 2019, 00:00

  • RE1 THE IMPACT OF REAL-WORLD EVIDENCE ON REIMBURSEMENT SUBMISSIONS: ARE WE CLEAR ON CURRENT PRACTICES?

    Oct 1, 2019, 00:00

  • TP3 Estudio de utilizacion de drogas: Descripción del uso de inmunoglobulina intravenosa humana en un Hospital Universitario de Bogotá, Colombia

    Oct 1, 2019, 00:00

  • PCN25 COST-EFFECTIVENESS OF NIVOLUMAB IN FIRST-LINE TREATMENT OF ADVANCED MELANOMA REGARDLESS OF BRAF MUTATION STATUS FROM A BRAZILIAN PUBLIC HEALTHCARE SYSTEM

    Oct 1, 2019, 00:00

  • CV4 EVALUACION DE LOS MOTIVOS DE LA OMISION DE RETIROS DE MEDICAMENTOS PENDIENTES EN LA OFICINA DE FARMACIA. POSIBLES SOLUCIONES

    Oct 1, 2019, 00:00

  • PMS3 PSYCHOLOGY CONSULTATION FOR PATIENTS WITH RHEUMATOID ARTHRITIS - A LOW-COST INTERVENTION WITH GREAT BENEFITS

    Oct 1, 2019, 00:00

  • TP4 REAL-WORLD PATIENT CHARACTERISTICS AND OUTCOMES OF RESECTED STAGE III MELANOMA PATIENTS IN ARGENTINA AND BRAZIL

    Oct 1, 2019, 00:00

  • PNS35 THE EFFECT OF FINANCIAL INCENTIVE ON RETAINING DENTISTS IN RURAL AREAS IN THAILAND

    Oct 1, 2019, 00:00

  • PCN62 PRELIMIANARY ANALYSIS OF TIROSINE KINASE INHIBITOR THERAPY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA A FIVE YEARS FOLLOW-UP FROM A REAL WORLD COHORT

    Oct 1, 2019, 00:00

  • PDB1 CALIDAD DE VIDA ASOCIADA CON OBESIDAD EN PACIENTES MEXICANOS

    Oct 1, 2019, 00:00

  • CN4 ANÁLISIS DE COSTO-UTILIDAD E IMPACTO PRESUPUESTARIO DE LA ENZALUTAMIDA PARA EL TRATAMIENTO DEL CÁNCER DE PRÓSTATA RESISTENTE A LA CASTRACIÓN NO METASTÁSICO (CPRCNM) EN ARGENTINA

    Oct 1, 2019, 00:00

  • PSU2 EFECTIVIDAD Y SEGURIDAD DEL USO DE LOS IMPLANTES DE AHMED, MOLTENO Y BAERVELDT EN PACIENTES OPERADOS CON GLAUCOMA CRONICO: UN META-ANALISIS EN RED

    Oct 1, 2019, 00:00

  • EP2 PUBLIC HEALTH AND ECONOMIC IMPACT OF A QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM FOR FEMALES AGED 9 YEARS IN EL SALVADOR

    Oct 1, 2019, 00:00

  • PMH8 EXPERIENCES AND HEALTH NEEDS OF ASYLUM SEEKERS AND REFUGEES OF LATIN AMERICAN ORIGIN IN CHILE

    Oct 1, 2019, 00:00

  • PMS19 MANAGEMENT AND COSTS OF THERAPY FOR OSTEOARTHRITIS

    Oct 1, 2019, 00:00

  • PMU1 POTENTIAL PRODUCTIVITY YEARS OF LIFE LOST RELATED TO DEATHS CAUSED BY RESIDENTIAL RADON AND BONE LEAD IN COLOMBIA, 2016

    Oct 1, 2019, 00:00

  • PCN44 DESIGUALDADES EN EL DIAGNÓSTICO DE CÁNCER DE CÉRVIX EN LAS REGIONES DE COLOMBIA

    Oct 1, 2019, 00:00

  • PUK7 ANALISIS DE EFECTIVIDAD Y SEGURIDAD DE MIRABEGRON EN PACIENTES CON SINDROME DE VEJIGA HIPERACTIVA

    Oct 1, 2019, 00:00

  • PRO14 COMPARAR A INCIDÊNCIA DE COMORBIDADES NO TRATAMENTOS DE MIELOMA MÚLTIPLO ENTRE AS TERAPIAS DO SISTEMA DE SAÚDE BRASILEIRO (SUS) COM AS AINDA NÃO INCORPORADAS

    Oct 1, 2019, 00:00

  • PNS59 IMPACTO DEL MODELO DE RIESGO COMPARTIDO EN LA TASA DE EVENTOS HOSPITALARIOS DE UN SEGURO VOLUNTARIO EN COLOMBIA

    Oct 1, 2019, 00:00

  • PIN4 A BUDGET IMPACTO ANALYSIS OF TENOFOVIR ALAFENAMIDE/EMTRICITABINE (DESCOVY®) FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION IN PATIENTS AGED 12 YEARS AND OLDER, IN MEXICO

    Oct 1, 2019, 00:00

  • PND4 ANALISIS DE MINIMIZACION DE COSTOS DE TOPIRAMATO DE LIBERACION PROLONGADA PARA LA PREVENCION DE MIGRAÑA EN ADULTOS Y ADOLESCENTES A PARTIR DE LOS 12 AÑOS

    Oct 1, 2019, 00:00

  • PND12 WORK PRODUCTIVITY AND DAILY ACTIVITIES IMPAIRMENT (WPAI) IN CHILEAN PATIENTS WITH MIGRAINE: PERSPECTIVES ON INDIRECT-COSTS DRIVERS

    Oct 1, 2019, 00:00

  • PNS15 DOES FOOD INSECURITY AFFECT PERFORMANCE AT SCHOOL? EVIDENCE FROM BRAZIL

    Oct 1, 2019, 00:00

  • PIN26 PRINCIPALES ESQUEMAS ANTIRRETROVIRALES USADOS EN LAS PERSONAS QUE VIVEN CON EL VIH EN COLOMBIA. 2018

    Oct 1, 2019, 00:00

  • PNS45 APPLYING A RAPID REVIEW METHODOLOGY TO INFORM THE UPDATE OF ARGENTINA'S HEALTH BENEFIT PACKAGE

    Oct 1, 2019, 00:00

  • PRO11 ANÁLISIS DE SERIE DE CASOS DE PACIENTES CON DIAGNÓSTICO DE HEMOFILIA A CON INHIBIDORES EN HOSPITALES DE ALTA COMPLEJIDAD EN ECUADOR

    Oct 1, 2019, 00:00

  • PCN39 ACCESS TO MEDICAL INTERVENTIONS IN BRAZIL: THE ROLE OF CLINICAL RESEARCH AND OF HEALTH JUDICIALIZATION

    Oct 1, 2019, 00:00

  • PNS3 BRAZILIAN PHARMACEUTICAL INDUSTRY: THE IMPACT OF PUBLIC POLICIES AIMED AT FOSTERING LOCAL MANUFACTURING

    Oct 1, 2019, 00:00

  • PDG10 DRUGS WITH DISCONTINUED PRODUCTION: A DESCRIPTIVE ANALYSIS OF THE BRAZILIAN SCENARIUM

    Oct 1, 2019, 00:00

  • PDB10 COST-EFFECTIVENESS ANALYSIS OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN TYPE 1 DIABETES MELLITUS COMPARED WITH MULTIPLE DAILY INJECTIONS IN THE RUSSIAN FEDERATION

    Oct 1, 2019, 00:00

  • HI4 ADHERENCE TO TREATMENT IS ASSOCIATED WITH GOOD CLINICAL RESULTS IN PATIENTS TREATED WITH BIOLOGICAL THERAPY IN A CENTER OF EXCELLENCE IN RHEUMATOID ARTHRITIS

    Oct 1, 2019, 00:00

  • PCN13 EVENTOS ADVERSOS ASOCIADOS A LOS TRATAMIENTOS DEL CARCINOMA UROTERIAL DE VEJIGA Y EL CARCINOMA DE CELULAS RENALES: ESTIMACION DE COSTOS DIRECTOS PARA ARGENTINA

    Oct 1, 2019, 00:00

  • PCN24 COST-EFFECTIVENESS OF NIVOLUMAB COMBINED WITH IPILIMUMAB IN FIRST-LINE TREATMENT OF ADVANCED MELANOMA FOR PATIENTS WITH BRAF+ MUTATION FROM A BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE

    Oct 1, 2019, 00:00

  • PRO9 PUBLIC PURCHASES OF ECULIZUMABE BY THE BRAZILIAN MINISTRY OF HEALTH: A PROFILE OF VOLUMES AND EXPENSES FROM 2007 TO 2018

    Oct 1, 2019, 00:00

  • PIN20 OVERVIEW OF MORTALITY DUE TO ANTIMICROBIAL RESISTANT INFECTIONS

    Oct 1, 2019, 00:00

  • CM4 TIME TO TREATMENT EFFECT, EVENT-FREE SURVIVAL, AND MOTOR MILESTONE ACHIEVEMENT IN TYPE I SPINAL MUSCULAR ATROPHY PATIENTS TREATED WITH ONASEMNOGENE ABEPARVOVEC (AVXS-101) OR NUSINERSEN CONTRASTED TO NATURAL HISTORY

    Oct 1, 2019, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8 (current)
  • 9
  • 10
  • »